Life Sciences Group Of The Year: Ropes & Gray
Ropes & Gray LLP guided Gilgamesh Pharmaceuticals in a potentially $1.2 billion deal with AbbVie and advised Novo Nordisk in eight licensing and mergers and acquisitions transactions for novel obesity and...To view the full article, register now.
Already a subscriber? Click here to view full article